Retrospective Cohort Study
Copyright ©The Author(s) 2021.
World J Hepatol. Jan 27, 2022; 14(1): 209-223
Published online Jan 27, 2022. doi: 10.4254/wjh.v14.i1.209
Table 4 Multivariate analysis of factors associated with overall survival
Variable
Adjusted HR
95%CI
P value
Age1.0390.999-1.0800.054
Sex
MaleRef
Female1.8740.984-3.5720.056
Location of primary tumor
RectumRef
Right1.1800.572-2.4350.654
Left 0.9430.427-2.0840.884
Regional LN metastasis
NoRef
Yes1.9551.031-3.7070.040a
Time of diagnosis of liver metastasis, %
SynchronousRef
Metachronous
Disease-free interval < 12 mo1.1920.431-3.2950.735
Disease-free interval ≥ 12 mo0.6680.324-1.3780.275
Synchronous extrahepatic metastasis
NoRef
Yes2.4540.308-19.5720.397
Preoperative CEA level
< 200 ng/mLRef
≥ 200 ng/mL0.4950.137-1.7850.282
Systemic chemotherapy before liver resection
NoRef
Yes1.0310.363-2.9290.954
Number of liver metastases
< 5 lesionsRef
≥ 5 lesions2.9621.174-7.4730.022a
Size of the largest liver lesion
< 4 cmRef
≥ 4 cm2.9831.343-6.6250.007a
Concurrent ablation
NoRef
Yes1.2410.436-3.5330.685
Operative approach
LaparoscopicRef
Open1.6550.873-3.1370.123
Requirement of blood transfusion, %
YesRef
No0.6810.320-1.4510.320